Changes in Proteomic Features Induced by Insulin on Vascular Smooth Muscle Cells from Spontaneous Hypertensive Rats In Vitro

Cell Biochemistry and Biophysics

Volumn 58, Issue 2, 2010, Pages 97-106

  Wang, Yan ^a   Zhang, Bo ^a   Bai, Yun ^a   Zeng, Chunyu ^b   Wang, Xukai ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

SM actin; Comparative proteomics; Insulin; Matrix gla protein; Osteopontin; VSMC phenotype

Indexed keywords

INSULIN;

ANIMAL; ARTICLE; CELL MOTION; CELL PROLIFERATION; CYTOSKELETON; DRUG EFFECT; GENE EXPRESSION PROFILING; MALE; METABOLISM; PATHOLOGY; PHENOTYPE; PROTEOMICS; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CYTOSKELETON; GENE EXPRESSION PROFILING; INSULIN; MALE; MUSCLE, SMOOTH, VASCULAR; PHENOTYPE; PROTEOMICS; RATS; RATS, INBRED SHR;

RATTUS;

EID: 77956787525     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-010-9096-x     Document Type: Article

References (36)

1. Yamada, H., Tsushima, T., Murakami, H., Uchigata, Y., & Iwamoto, Y. (2002). Potentiation of mitogenic activity of platelet-derived growth factor by physiological concentrations of insulin via the MAP kinase cascade in rat A10 vascular smooth muscle cells. International Journal of Experimental Diabetes Research, 3, 131-144.
2. Doronzo, G., Russo, I., Mattiello, L., Anfossi, G., Bosia, A., & Trovati, M. (2004). Insulin activates vascular endothelial growth factor in vascular smooth muscle cells: Influence of nitric oxide and of insulin resistance. European Journal of Clinical Investigation, 34, 664-673.
3. Sourij, H., Schmoelzer, I., Dittrich, P., Paulweber, B., Iglseder, B., & Wascher, T. C. (2008). Insulin resistance as a risk factor for carotid atherosclerosis: A comparison of the homeostasis model assessment and the short insulin tolerance test. Stroke, 39, 1349-1351.
4. Pyörälä, M., Miettinen, H., Halonen, P., Laakso, M., & Pyörälä, K. (2000). Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: The 22-year follow-up results of the Helsinki policemen study. Arteriosclerosis, Thrombosis, and Vascular Biology, 20, 538-544.
5. Doronzo, G., Russo, I., Mattiello, L., Riganti, C., Anfossi, G., & Trovati, M. (2006). Insulin activates hypoxia-inducible factor-1 alpha in human and rat vascular smooth muscle cells via phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways: Impairment in insulin resistance owing to defects in insulin signaling. Diabetologia, 49, 1049-1063.
6. Wang, C. C., Gurevich, I., & Draznin, B. (2003). Insulin affects vascular smooth muscle cell phenotype and migration via distinct signaling pathways. Diabetes, 52, 2562-2569.
7. Deng, D. X., Spin, J. M., Tsalenko, A., Vailaya, A., Ben-Dor, A., Yakhini, Z., et al. (2006). Molecular signatures determining coronary artery and saphenous vein smooth muscle cell phenotypes: Distinct responses to stimuli. Arteriosclerosis, Thrombosis, and Vascular Biology, 26, 1058-1065.
8. Rzucidlo, E. M., Martin, K. A., & Powell, R. J. (2007). Regulation of vascular smooth muscle cell differentiation. Journal of Vascular Surgery, 45(Suppl A), 25A-32A.
9. Pandolfi, A., Grilli, A., Cilli, C., Patruno, A., Giaccari, A., Di Silvestre, S., et al. (2003). Phenotype modulation in cultures of vascular smooth muscle cells from diabetic rats: Association with increased nitric oxide synthase expression and superoxide anion generation. Journal of Cellular Physiology, 196, 378-385.
10. Hayashi, K., Shibata, K., Morita, T., Iwasaki, K., Watanabe, M., & Sobue, K. (2004). Insulin receptor substrate-1/SHP-2 interaction, a phenotype-dependent switching machinery of insulin-like growth factor-I signaling in vascular smooth muscle cells. The Journal of Biological Chemistry, 279, 40807-40818.
11. Muñoz, F. J., Jiménez, M., Melón, J., & Ruiz-Torres, A. (1998). Phenotypic changes in vascular smooth muscle cells during aging: Insulin effect on migration. Gerontology, 44, 149-152.
12. Faries, P. L., Rohan, D. I., Wyers, M. C., Marin, M. L., Hollier, L. H., Quist, W. C., et al. (2002). Vascular smooth muscle cells derived from atherosclerotic human arteries exhibit greater adhesion, migration, and proliferation than venous cells. Journal of Surgical Research, 104, 22-28.
13. Yasunari, K., Kohno, M., Kano, H., Yokokawa, K., Minami, M., & Yoshikawa, J. (1999). Antioxidants improve impaired insulin-mediated glucose uptake and prevent migration and proliferation of cultured rabbit coronary smooth muscle cells induced by high glucose. Circulation, 99, 1370-1378.
14. Arnqvist, H. J., Bornfeldt, K. E., Chen, Y., & Lindström, T. (1995). The insulin-like growth factor system in vascular smooth muscle: Interaction with insulin and growth factors. Metabolism, 44, 58-66.
15. Okuda, T., Sumiya, T., Mizutani, K., Tago, N., Miyata, T., Tanabe, T., et al. (2002). Analyses of differential gene expression in genetic hypertensive rats by microarray. Hypertension Research, 25, 249-255.
16. Boccardi, C., Cecchettini, A., Caselli, A., Camici, G., Evangelista, M., Mercatanti, A., et al. (2007). A proteomic approach to the investigation of early events involved in the activation of vascular smooth muscle cells. Cell and Tissue Research, 329, 119-128.
17. Fukuda, N., Hu, W. Y., Satoh, C., Nakayama, M., Kishioka, H., Kubo, A., et al. (1999). Contribution of synthetic phenotype on the enhanced angiotensin II-generating system in vascular smooth muscle cells from spontaneously hypertensive rats. Journal of Hypertension, 17, 1099-1107.
18. King, K. E., Iyemere, V. P., Weissberg, P. L., & Shanahan, C. M. (2003). Krüppel-like factor 4 (KLF4/GKLF) is a target of bone morphogenetic proteins and transforming growth factor beta 1 in the regulation of vascular smooth muscle cell phenotype. The Journal of Biological Chemistry, 278, 11661-11669.
19. Ross, R. (1971). The smooth muscle cell: II Growth of smooth muscle in culture and formation of elastic fibers. Journal of Cell Biology, 50, 172-186.
20. Liu, S., Zhang, Y., Xie, X., Hu, W., Cai, R., Kang, J., et al. (2007). Application of two-dimensional electrophoresis in the research of retinal proteins of diabetic rat. Cellular and Molecular Immunology, 4, 65-70.
21. Shanahan, C. M., Cary, N. R., Osbourn, J. K., & Weissberg, P. L. (1997). Identification of osteoglycin as a component of the vascular matrix differential expression by vascular smooth muscle cells during neointima formation and in atherosclerotic plaques. Arteriosclerosis, Thrombosis, and Vascular Biology, 17, 2437-2447.
22. Hu, W. Y., Fukuda, N., Ikeda, Y., Suzuki, R., Tahira, Y., Takagi, H., et al. (2003). Human-derived vascular smooth muscle cells produce angiotensin II by changing to the synthetic phenotype. Journal of Cellular Physiology, 196, 284-292.
23. Hao, H., Ropraz, P., Verin, V., Camenzind, E., Geinoz, A., Pepper, M. S., et al. (2002). Heterogeneity of smooth muscle cell populations cultured from pig coronary artery. Arteriosclerosis, Thrombosis, and Vascular Biology, 22, 1093-1099.
24. Chadjichristos, C. E., Morel, S., Derouette, J. P., Sutter, E., Roth, I., Brisset, A. C., et al. (2008). Targeting connexin 43 prevents platelet-derived growth factor-BB-induced phenotypic change in porcine coronary artery smooth muscle cells. Circulation Research, 102, 653-660.
25. Lin, Z. H., Fukuda, N., Jin, X. Q., Yao, E. H., Ueno, T., Endo, M., et al. (2004). Complement 3 is involved in the synthetic phenotype and exaggerated growth of vascular smooth muscle cells from spontaneously hypertensive rats. Hypertension, 44, 42-47.
26. Begum, N., & Ragolia, L. (2000). High glucose and insulin inhibit VSMC MKP-1 expression by blocking iNOS via p38 MAPK activation. American Journal of Physiology. Cell Physiology, 278, C81-C91.
27. Opitz, F., Schenke-Layland, K., Cohnert, T. U., & Stock, U. A. (2007). Phenotypical plasticity of vascular smooth muscle cells-effect of in vitro and in vivo shear stress for tissue engineering of blood vessels. Tissue Engineering, 13, 2505-2514.
28. Duan, C. (2003). The chemotactic and mitogenic responses of vascular smooth muscle cells to insulin-like growth factor-I require the activation of ERK1/2. Molecular and Cellular Endocrinology, 206, 75-83.
29. Meng, D., Lv, D. D., & Fang, J. (2008). Insulin-like growth factor-I induces reactive oxygen species production and cell migration through Nox4 and Rac1 in vascular smooth muscle cells. Cardiovascular Research, 80, 299-308.
30. Radhakrishnan, Y., Maile, L. A., Ling, Y., Graves, L. M., & Clemmons, D. R. (2008). Insulin-like growth factor-I stimulates Shc-dependent phosphatidylinositol 3-kinase activation via Grb2-associated p85 in vascular smooth muscle cells. The Journal of Biological Chemistry, 283, 16320-16331.
31. Lim, H. J., Park, H. Y., Ko, Y. G., Lee, S. H., Cho, S. Y., Lee, E. J., et al. (2004). Dominant negative insulin-like growth factor-1 receptor inhibits neointimal formation through suppression of vascular smooth muscle cell migration and proliferation, and induction of apoptosis. Biochemical and Biophysical Research Communications, 325, 1106-1114.
32. Shanahan, C. M., Weissberg, P. L., & Metcalfe, J. C. (1993). Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. Circulation Research, 73, 193-204.
33. Kaartinen, M. T., Murshed, M., Karsenty, G., & McKee, M. D. (2007). Osteopontin upregulation and polymerization by transglutaminase 2 in calcified arteries of Matrix Gla protein-deficient mice. Journal of Histochemistry and Cytochemistry, 55, 375-386.
34. Steitz, S. A., Speer, M. Y., Curinga, G., Yang, H. Y., Haynes, P., Aebersold, R., et al. (2001). Smooth muscle cell phenotypic transition associated with calcification: Upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circulation Research, 89, 1147-1154.
35. Abe, K., Nakashima, H., Ishida, M., Miho, N., Sawano, M., Soe, N. N., et al. (2008). Angiotensin II-induced osteopontin expression in vascular smooth muscle cells involves Gq/11, Ras, ERK, Src and Ets-1. Hypertension Research, 31, 987-998.
36. Boccardi, C., Cecchettini, A., Caselli, A., Camici, G., Evangelista, M., Mercatanti, A., et al. (2007). A proteomic approach to the investigation of early events involved in vascular smooth muscle cell activation. Cell and Tissue Research, 328, 185-195.